597 filings
8-K
ELTP
Elite Pharmaceuticals Inc
5 Jun 24
Changes in Registrant's Certifying Accountant
4:07pm
8-K
ELTP
Elite Pharmaceuticals Inc
20 May 24
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
4:30pm
S-8
ELTP
Elite Pharmaceuticals Inc
28 Mar 24
Registration of securities for employees
4:06pm
S-8
ELTP
Elite Pharmaceuticals Inc
28 Mar 24
Registration of securities for employees
4:06pm
8-K
ELTP
Elite Pharmaceuticals Inc
14 Feb 24
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024
4:55pm
8-K
wlxar x7a
26 Dec 23
Regulation FD Disclosure
4:20pm
8-K
53ec876nqqetwx0 mgun
12 Dec 23
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR® to Marketing Partner Prasco, LLC
4:20pm
8-K
qxt2wzf1y82wz
14 Nov 23
Results of Operations and Financial Condition
5:22pm
8-K
lydbdhcrwpr
25 Sep 23
Regulation FD Disclosure
4:15pm
8-K
fk51 f5hofs1n
7 Sep 23
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
4:05pm
8-K
rfgzrsrl0ktg4rq
14 Aug 23
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024
5:30pm
8-K
yk9m9jy5m0zljs
17 Jul 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
s3zfchxd
29 Jun 23
Results of Operations and Financial Condition
5:15pm
8-K
rmup40bz
3 May 23
Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer
4:15pm
8-K
3voy y7j31a4b5wtui
20 Apr 23
Regulation FD Disclosure
10:05am